Are you interested in space travel, genetic engineering and other futurist tech trends transforming our world/society? If so you will love this.
Our Expert Panelists:
Aubrey de Grey is a Cambridge researcher and Chief Science Officer of SENS Research Foundation focused on aging and extending human longevity. He proposes that the first human beings who will live to 1,000 years old have already been born. In addition to his research, Aubrey is editor-in-chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging(2007). De Grey’s research focuses on whether regenerative medicine can prevent the aging process. He works on the development of what he calls “Strategies for Engineered Negligible Senescence” (SENS), a collection of proposed techniques to rejuvenate the human body and stop aging. To this end, he has identified seven types of molecular and cellular damage caused by essential metabolic processes. SENS is a proposed panel of therapies designed to repair this damage.
Mike Selden is co-founder and CEO of Finless Foods, a food startup that uses cutting-edge cellular-agriculture technologies to grow marine-animal cells, creating fish and seafood products enjoyed around the world. They are working toward a sci-fi, soon-here world where everyone has access to healthy, delectable seafood, without the environmental devastation or the health hazards of traditional fishing and aquatic farming.
Jenny Rooke is the founder and managing partner or Genoa Ventures (formerly 5 Prime Ventures) where she funds & builds companies that change the way science gets done with new tools and technologies. She has a PhD in Genetics, a Bachelors in physics, and a background in computer science and works closely with early-stage life science start-ups on issues of fundraising, market & product strategy, and business development.
We cover a wide range of topics from genetic engineering and human longevity to personalized medicine, pharma, manufactured meats and much more…
Are you an accredited investor? Apply to join our angel syndicate if you’d like to access our deal flow.